Top

Reactions Weekly

Published in:

01-02-2023 | Myelodysplastic Syndrome | Case report

Pembrolizumab

Lack of efficacy: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Grenda A, et al. Efficacy of Dabrafenib and Trametinib in a Patient with Squamous-Cell Carcinoma, with Mutation p.D594G in BRAF and p.R461* in NF1 Genes-A Case Report with Literature Review. [Review]. International Journal of Molecular Sciences 24: No. 2, et al. Jan 2023. Available from: URL: http://doi.org/10.3390/ijms24021195

Title: Pembrolizumab
Lack of efficacy: case report
Publication date: 01-02-2023
Publisher: Springer International Publishing
Keyword: Myelodysplastic Syndrome
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-33992-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Pembrolizumab

Lack of efficacy: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Apixaban

Lenvatinib

Azathioprine

Aspirin/folic-acid

Heparin

Famotidine/papain